from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2286c/-

LFCtreatmentdescriptionclass of inhibitor

-0.796

Amikacinug/mL Amikacintranslation

0.539

Cap5-10ug/mL Capreomycintranslation

0.328

Rox10-50 ug/mL Roxithromycintranslation

-0.228

SM2-5 ug/mL Streptomycintranslation

0.006

Tet5-10 ug/mL Tetracyclinetranslation

-1.167

Rif0.2-5ug/mL Rifampicintranscription

0.315

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.343

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.626

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.244

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.587

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.527

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.062

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.611

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.151

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.059

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.478

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.270

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.097

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.703

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.726

KCN5-20 ug/mL Potassium cyaniderespiration

-0.246

NaN30.2-2 mM Sodium aziderespiration

-0.343

Nigericin50 uM Nigericinrespiration

0.228

TRC10-150 ug/mL Triclosanrespiration

1.467

TRZ10-25 ug/mL Thioridazinerespiration

-0.090

Valinomycin0.5-10 uM Valinomycinrespiration

0.089

ZnSO42 mM ZnSO4respiration

0.109

menadione6-10 ug/mL Menadionerespiration

0.500

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.214

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.420

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.804

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.286

NRP_1Non-replicating persistence stage 1dosRassociated

0.003

Amp0.2mg/mL AmpicillincellWall

-0.218

Cephalexin20-100 ug/mL CephalexincellWall

-0.296

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.863

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.528

EMB10-20 ug/mL EthambutolcellWall

-0.426

Eta12-40 ug/mL EthionamidecellWall

-0.372

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.341

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.402

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.705

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.459

BZA0.12 mg/mL BenzamidearomaticAmides

0.136

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.476

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.003

H2O24 mM hydrogen peroxideDNAdamaging

-0.075

Levo10 ug/mL LevofloxacinDNAdamaging

0.200

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.970

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.167

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.193

UVUV-irradiationDNAdamaging

1.790

ARP41-4 ug/mL Antitubercular compound ARP4?

0.543

Antimycin12.5-50 ug/mL Antimycin A?

0.040

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.539

PA_110-50 ug/mL Antitubercular compound PA-1?

0.552

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.020

PA8240.2-2 ug/mL PA-824?

-0.616

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.426

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.016

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.839

methoxatin10-20 ug/mL Methoxatin?